Clinical Trials
5 trialsNCT03575949 2024-05-14
Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
Phase NA Completed
NCT01020097 2020-04-28
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03611205 2019-08-07
Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation Therapy
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT00038038 2012-08-01
Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT00634777 2011-07-20
pet
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase NA Unknown